NRX Pharmaceuticals Inc (NRXP)
3.52
+0.29
(+8.98%)
USD |
NASDAQ |
May 16, 16:00
3.49
-0.03
(-0.85%)
After-Hours: 05:53
NRX Pharmaceuticals Total Liabilities (Quarterly): 19.05M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.05M |
| September 30, 2023 | 19.33M |
| June 30, 2023 | 22.62M |
| March 31, 2023 | 22.06M |
| December 31, 2022 | 18.41M |
| September 30, 2022 | 8.042M |
| Date | Value |
|---|---|
| June 30, 2022 | 7.081M |
| March 31, 2022 | 11.91M |
| December 31, 2021 | 11.92M |
| September 30, 2021 | 36.28M |
| June 30, 2021 | 35.98M |
| December 31, 2020 | 46.71M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.081M
Minimum
Jun 2022
46.71M
Maximum
Dec 2020
21.62M
Average
19.19M
Median
Total Liabilities (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.198M |
| Achieve Life Sciences Inc | 20.57M |
| EyePoint Pharmaceuticals Inc | 79.31M |
| Nanoviricides Inc | 0.9511M |
| GlycoMimetics Inc | 5.294M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.315M |
| Shareholders Equity (Quarterly) | -11.73M |